Medicenna to Present at the Oppenheimer 33rd Annual Healthcare Conference

March 2, 2023

https://www.globenewswire.com/news-release/2023/03/02/2619148/0/en/Medicenna-to-Present-at-the-Oppenheimer-33rd-Annual-Healthcare-Conference.html

TORONTO and HOUSTON, March 02, 2023 (GLOBE NEWSWIRE) — Medicenna Therapeutics Corp. (“Medicenna” or “the Company”) (NASDAQ:MDNA TSX:MDNA), a clinical stage immunotherapy company, today announced that Dr. Fahar Merchant, President, CEO and Chairman of the Board of Medicenna, will participate in a fireside chat at the Oppenheimer 33rd Annual Healthcare Conference, which is scheduled to take place virtually from March 13 – 15, 2023.

Read more at globenewswire.com

Related news for (MDNA)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.